How the Long-term Use of Aspirin Impacts Mortality, Renal Deterioration in Patients With Chronic Kidney Disease

Jun Ling Lu, MD, assistant professor, University of Tennessee Health Science Center, addresses the study findings regarding how the long-term use of aspirin impacts mortality and renal deterioration in patients with chronic kidney disease.

Pharmacy Times interviewed Jun Ling Lu, MD, assistant professor, Department of Medicine, University of Tennessee Health Science Center, on her presentation at the American Society of Nephrology’s Kidney Week 2021 on the association between long-term aspirin use and the progression of kidney disease.

During the interview, Lu discussed the study findings investigating how the long-term use of aspirin impacts mortality and renal deterioration in patients with chronic kidney disease.

Related Videos
Credit: Lars Neumann - stock.adobe.com
Image Credit: Adobe Stock - peterschreiber.media
Conference attendees watching a speaker | Image credit: kasto - stock.adobe.com
Biosimilars | Image credit: lexiconimages - stock.adobe.com
Medical care team | Image credit: Iryna - stock.adobe.com
Pharmacist helping patient | Image credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com
Medical science laboratory | Image credit: alphaspirit - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.